参考文献/References:
[1] 中国骨关节炎诊疗指南专家组,中国老年保健协会疼痛病学分会.中国骨关节炎诊疗指南(2024版)[J].中华疼痛学杂志,2024,20(3):323-338.
[2] 王若瑜,尚赫,杨天翔,等.肠-关节轴在膝关节骨关节炎中的发病机制及靶向干预[J].国际骨科学杂志,2026,47(1):24-27.
[3] 白露,房洋,韩冷,等.基于胆汁酸代谢介导免疫调控的研究进展[J].生命科学,2026,38(3):454-462.
[4] 王思玉,乔喆,王帅,等.胆汁酸代谢与肠道菌群失调相关疾病中医辨证论治的相关研究进展[J].世界中西医结合杂志,2026,21(1):187-191.
[5] 高晖.胆汁酸含量减少介导孕期咖啡因暴露所致成年雄性子代骨关节炎易感[D].武汉:武汉大学,2021.
[6] TRAUNER M,KARPEN S J,DAWSON P A.Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease[J].Hepatology,2025,82(4):855-876.
[7] LI X J,FANG C,ZHAO R H,et al.Bile acid metabolism in health and ageing-related diseases[J].Biochem Pharmacol,2024,225:116313.
[8] ALREHAILI B D,LEE M,TAKAHASHI S,et al.Bile acid conjugation deficiency causes hypercholanemia,hyperphagia,islet dysfunction,and gut dysbiosis in mice[J].Hepatol Commun,2022,6(10):2765-2780.
[9] MOHANTY I,ALLABAND C,MANNOCHIO-RUSSO H,et al.The changing metabolic landscape of bile acids-keys to metabolism and immune regulation[J].Nat Rev Gastroenterol Hepatol,2024,21(7):493-516.
[10] XIANG T,DENG Z,YANG C,et al.Bile acid metabolism regulatory network orchestrates bone homeostasis[J].Pharmacol Res,2023,196:106943.
[11] WEI J,ZHANG Y,HUNTER D,et al.The gut microbiome-joint axis in osteoarthritis[J].Sci Bull,2023,68(8):759-762.
[12] RESTA S,BARDI E,D'ARRIGO D,et al.Gut microbiota-targeted interventions for gut-joint axis modulation in experimental osteoarthritis:a systematic review of animal studies[J].J Funct Foods,2025,135:107078.
[13] JEYARAMAN M,RAM P R,JEYARAMAN N,et al.The gut-joint axis in osteoarthritis[J].Cureus,2023,15(11):e48951.
[14] WANG T,XU Y,ZHA H,et al.The “gut microbiota-ferroptosis axis”:a hypothesis for osteoarthritis pathogenesis and therapeutic implications[J].Front Microbiol,2025,16:1685962.
[15] WANG W,LIU H,ZHANG M,et al.Integrative multi-omics analysis reveals gut microbiota-derived metabolites and immune regulatory pathways in osteoarthritis pathogenesis[J].J Orthop Surg Res,2026,21(1):87.
[16] QIN R,YU P,WANG H,et al.Gut-bone axis crosstalk:microbiota-driven immune-metabolic-neural networks in bone disorders and precision interventions[J].J Orthop Translat,2026,58:101126.
[17] ZHAO M,ZHANG L,LIU Z.Gut microbiota-mediated pain sensitization:mechanisms and therapeutic implications[J].Front Pain Res,2025,6:1626515.
[18] HLADKYKH F V,LIADOVA T I,MATVIEIENKO M S,et al.Central sensitization and nociplastic pain:shared mechanisms in fibromyalgia,osteoarthritis,and inflammatory arthritis[J].J Pain Res,2026,19:571311.
[19] HONG S W,PIAO L,CHO E H,et al.Effect of microglial activity on gut microbiota in rats with neuropathic pain[J].Int J Mol Sci,2025,26(11):5181.
[20] BRITTAIN R S A,BRIBIESCAS R G,JASIENSKA G.Industrialization increases the estrogen-recycling capacity of the gut microbiome[J].Proc Natl Acad Sci U S A,2026,123(16):e2523589123.
[21] ATASOY-ZEYBEK A,SHOWEL K K,NAGELLI C V,et al.The intersection of aging and estrogen in osteoarthritis[J].NPJ Womens Health,2025,3(1):15.
[22] SUN X,SHUKLA M,WANG W,et al.Unlocking gut-liver-brain axis communication metabolites:energy metabolism,immunity and barriers[J].NPJ Biofilms Microbiomes,2024,10(1):136.
[23] GUAN Z,XUANQI Z,ZHU J,et al.Estrogen deficiency induces bone loss through the gut microbiota[J].Pharmacol Res,2023,196:106930.
[24] HUANG H,LEI H,YANG F,et al.Activation of the bile acid receptor GPBAR1(TGR5)ameliorates interleukin-1β(IL-1β)-induced chondrocytes senescence[J].Biomed Pharmacother,2018,106:1713-1719.
[25] ZHENG X Q,HUANG J,YUAN W Q,et al.Gut microbiota preserves bone mass through modulating the hyodeoxycholic acid-TGR5 axis[J].Gut Microbes,2025,17(1):2593088.
[26] KUHN K A,YOMOGIDA K,KNOOP K,et al.More than a leaky gut:how gut priming shapes arthritis[J].Nat Rev Rheumatol,2025,21(9):513-525.
[27] HASSAN RIZVI S M M,SHAMI A,KAN Y,et al.FXR in bone metabolism:an emerging regulator[J].iScience,2026,29(3):114842.
[28] YANG Y,HAO C,JIAO T,et al.Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signaling[J].Science,2025,388(6742):eadt0548.
[29] LI J,YE J,YANG T,et al.Bile acids metabolism in symptomatic hand osteoarthritis[J].Arthritis Rheumatol,2026,78(7):1465-1476.
[30] FU K,SI S,JIN X,et al.Exploring antidiabetic drug targets as potential disease-modifying agents in osteoarthritis[J].EBioMedicine,2024,107:105285.
[31] JAMAL N,HOLLABAUGH W,SCOTT L,et al.Unravelling the ties that bind:the intersection of obesity,osteoarthritis,and inflammatory pathways with emphasis on glucagon-like peptide-1 agonists[J].Clin Obes,2025,15(1):e12700.
[32] LIAN W S,WANG F S.Gut microbiota and articular cartilage interacting axis:links with host genetics,chromatin dynamics and potential mechanisms in aging-related osteoarthritis[J].Osteoarthritis Cartilage,2024,32:S464-S465.
[33] LIU C,CAO Y,YANG X,et al.Tauroursodeoxycholic acid suppresses endoplasmic reticulum stress in the chondrocytes of patients with osteoarthritis[J].Int J Mol Med,2015,36(4):1081-1087.
[34] ARAI Y,CHOI B,KIM B J,et al.Tauroursodeoxycholic acid counters osteoarthritis by regulating intracellular cholesterol levels and membrane fluidity of degenerated chondrocytes[J].Biomater Sci,2019,7(8):3178-3189.
[35] SHINE B K,LI Q,SONG M,et al.Efficacy and safety of Latilactobacillus sakei LB-P12 in patients with knee osteoarthritis:an exploratory randomized,double-blind,placebo-controlled clinical trial[J].Sci Rep,2025,15(1):25980.
[36] GUZIOR D V,QUINN R A.Review:microbial transformations of human bile acids[J].Microbiome,2021,9(1):140.
[37] BLIDDAL H,BAYS H,CZERNICHOW S,et al.Once-weekly semaglutide in persons with obesity and knee osteoarthritis[J].N Engl J Med,2024,391(17):1573-1583.
[38] BILGIN E,VENERITO V,BOGDANOS D P.Glucagon-like peptide-1(GLP-1)receptor agonists in rheumatology:a review of current evidence and future directions[J].Auto-immun Rev,2025,24(9):103864.
[39] ZHANG X,JIANG J,XU J,et al.Liraglutide,a glucagon-like peptide-1 receptor agonist,ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes[J].BMC Musculoskelet Disord,2024,25(1):601.
[40] RYAN M,MEGYERI S,NUFFER W,et al.The potential role of GLP-1 receptor agonists in osteoarthritis[J].Pharmacotherapy,2025,45(3):177-186.
[41] MEUROT C,MARTIN C,SUDRE L,et al.Liraglutide,a glucagon-like peptide 1 receptor agonist,exerts analgesic,anti-inflammatory and anti-degradative actions in osteoarthritis[J].Sci Rep,2022,12(1):1567.
[42] URSINI F,CIAFFI J,CAPORALI R.If the evidence is there,why are GLP-1 receptor agonists not on-label for hip and knee osteoarthritis in overweight patients?[J].RMD Open,2025,11(3):e006025.
[43] PATHAK P,XIE C,NICHOLS R G,et al.Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism[J].Hepatology,2018,68(4):1574-1588.
[44] 卢一帆,徐无忌,熊辉,等.基于16S rDNA测序分析独活寄生汤对膝骨关节炎大鼠肠道菌群的影响[J].湖南中医药大学学报,2024,44(12):2277-2285.
[45] BIAN M,ZHU C,NIE A,et al.Guizhi Shaoyao Zhimu Decoction ameliorates gouty arthritis in rats via altering gut microbiota and improving metabolic profile[J].Phytomedicine,2024,131:155800.
[46] 顾富城,杨美鑫,吴伟欣,等.龟鹿二仙胶对膝骨关节炎大鼠肠道菌群的影响:机器学习与16S rDNA分析[J].中国组织工程研究,2026,30(4):1058-1072.
[47] LIU J,ZHANG D,ZHOU Y,et al.Fuzi alleviates cold-related rheumatoid arthritis via regulating gut microbiota and microbial bile acid metabolism[J].Chin Med,2025,20(1):64.
[48] ZHAO J A,ZHENG Y Z,WANG F,et al.Mulberry water extract alleviates osteoarthritis via Lactobacillus johnsonii-dependent bile acid restoration[J].Phytomedicine,2026,150:157679.
[49] 李兰清,许海樱,瞿领航,等.何首乌水提物及其活性成分大黄素通过调控胆固醇代谢抑制软骨细胞炎症缓解骨关节炎的研究[J].针灸和草药(英文),2023,3(2):96-106.
[50] TIAN F,CHEN T,XU W,et al.Curcumin compensates GLP-1 deficiency via the microbiota-bile acids axis and modulation in functional crosstalk between TGR5 and FXR in ob/ob mice[J].Mol Nutr Food Res,2023,67(22):e2300195.
相似文献/References:
[1]孟维娜,明立功,王新德,等.关节镜下清理联合腓骨近1/3段截骨治疗膝骨关节炎[J].中医正骨,2015,27(11):40.
[2]明立功,孟维娜,王新德,等.腓骨近端截骨治疗内侧间室膝骨关节炎的近期疗效观察[J].中医正骨,2015,27(10):25.
[3]张杰,王人彦,张玉柱.膝骨关节炎的治疗进展[J].中医正骨,2015,27(10):68.
[4]梁朝,蔡静怡,闫立,等.针刀疗法改善膝骨关节炎早期疼痛症状的疗效评价[J].中医正骨,2015,27(09):9.
LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):9.
[5]王建武,党建军,李强,等.四联疗法治疗膝骨关节炎[J].中医正骨,2015,27(08):44.
[6]刘红娟,郭会利,郭树农.云克联合中药治疗膝骨关节炎的护理[J].中医正骨,2015,27(08):75.
[7]陈卫衡.探索建立系统的膝骨关节炎中医临床科研范式
和理论体系[J].中医正骨,2015,27(07):1.
[8]郑春松,叶蕻芝,李西海,等.透骨消痛胶囊中补肾柔肝药和活血祛风药治疗
骨关节炎作用方式的计算机模拟比较[J].中医正骨,2015,27(07):6.
ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(补肾柔肝)drugs versus Huoxue Qufeng(活血祛风)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛胶囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):6.
[9]帅波,沈霖,杨艳萍,等.加味青娥丸治疗膝骨关节炎的作用机制研究[J].中医正骨,2015,27(07):15.
SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):15.
[10]梅其杰,袁长深,段戡,等.壮药骨痹方烫熨联合运动疗法治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):27.
MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):27.